Literature DB >> 22865293

Moyamoya arteriopathy.

Edward R Smith1.   

Abstract

OPINION STATEMENT: The arteriopathy of moyamoya is progressive and results in severe disability from cerebral ischemia. Once the diagnosis is confirmed with magnetic resonance imaging (MRI) and catheter angiography, initial measures should consist of administration of low dose aspirin (usually 81 mg daily, barring pre-existing contraindications), maintenance of good hydration and avoidance of hyperventilation (to reduce the risk of reflex cerebral vasoconstriction). Definitive treatment is predicated on surgical revascularization of the affected cerebral hemispheres. Operative treatment should be undertaken at a high-volume center with experienced surgeons and anesthesia staff. The specific technique employed depends on the individual presentation and surgeon preference, although most centers will offer indirect approaches such as pial synangiosis to children and young adults, with direct bypass often reserved for older patients or those presenting with crescendo symptoms. Follow-up is important, with postoperative imaging (either MRI or catheter angiogram) and office visits to confirm surgical efficacy and resolution of symptoms.

Entities:  

Year:  2012        PMID: 22865293     DOI: 10.1007/s11940-012-0195-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  21 in total

Review 1.  Moyamoya syndrome: a surgically treatable cause of stroke in the pediatric patient.

Authors:  R M Scott
Journal:  Clin Neurosurg       Date:  2000

Review 2.  Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist's perspective.

Authors:  Vijeya Ganesan
Journal:  Dev Med Child Neurol       Date:  2009-11-08       Impact factor: 5.449

3.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

4.  Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression.

Authors:  Ning Lin; Lissa Baird; McKenzie Koss; Kimberly E Kopecky; Evelyne Gone; Nicole J Ullrich; R Michael Scott; Edward R Smith
Journal:  Neurosurg Focus       Date:  2011-12       Impact factor: 4.047

Review 5.  Revascularisation surgery for paediatric moyamoya: a review of the literature.

Authors:  Lai-Wah Eva Fung; Dominic Thompson; Vijeya Ganesan
Journal:  Childs Nerv Syst       Date:  2005-02-05       Impact factor: 1.475

Review 6.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

Review 7.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

8.  Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.

Authors:  Edward R Smith; Craig D McClain; Matthew Heeney; R Michael Scott
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

9.  Introduction: moyamoya disease.

Authors:  R Michael Scott; Edward R Smith
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

10.  Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.

Authors:  S R Levine; S C Fagan; M S Pessin; R Silbergleit; J Floberg; J F Selwa; C M Vogel; K M Welch
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

View more
  5 in total

1.  Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.

Authors:  Erin M Hall; Jeffrey Leonard; Jodi L Smith; Kristin P Guilliams; Michael Binkley; Robert J Fallon; Monica L Hulbert
Journal:  Pediatr Blood Cancer       Date:  2016-04-22       Impact factor: 3.167

Review 2.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

3.  The collateral circulation in pediatric moyamoya disease.

Authors:  Gerasimos Baltsavias; Nadia Khan; Anton Valavanis
Journal:  Childs Nerv Syst       Date:  2014-11-07       Impact factor: 1.475

4.  Selective and superselective angiography of pediatric moyamoya disease angioarchitecture: the anterior circulation.

Authors:  Gerasimos Baltsavias; Anton Valavanis; Venko Filipce; Nadia Khan
Journal:  Interv Neuroradiol       Date:  2014-08-28       Impact factor: 1.610

5.  Comparison of Long-Term Effect Between Direct and Indirect Bypass for Pediatric Ischemic-Type Moyamoya Disease: A Propensity Score-Matched Study.

Authors:  Yahui Zhao; Junlin Lu; Shaochen Yu; Jiaxi Li; Xiaofeng Deng; Yan Zhang; Dong Zhang; Rong Wang; Hao Wang; Yuanli Zhao
Journal:  Front Neurol       Date:  2019-07-31       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.